1999
Effects of Long‐Acting Versus Short‐Acting Calcium Channel Blockers Among Older Survivors of Acute Myocardial Infarction
Gillman M, Ross‐Degnan D, McLaughlin T, Gao X, Spiegelman D, Hertzmark E, Goldman L, Soumerai S. Effects of Long‐Acting Versus Short‐Acting Calcium Channel Blockers Among Older Survivors of Acute Myocardial Infarction. Journal Of The American Geriatrics Society 1999, 47: 512-517. PMID: 10323641, DOI: 10.1111/j.1532-5415.1999.tb02562.x.Peer-Reviewed Original ResearchConceptsCalcium channel blockersAcute myocardial infarctionShort-acting calcium channel blockersCardiac rehospitalizationMyocardial infarctionChannel blockersRelative riskOlder survivorsActing calcium channel blockerSeparate Cox regression modelsDihydropyridine calcium channel blockerRetrospective cohort studyCoronary heart diseaseDrug claims dataCox regression modelDrug benefit programCause mortalityClinical characteristicsCohort studyEligible subjectsRehospitalization ratesAdverse outcomesHeart diseaseOutcome measuresRehospitalization
1997
Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997, 277: 115-21. PMID: 8990335, DOI: 10.1001/jama.277.2.115.Peer-Reviewed Original ResearchConceptsCalcium channel blockersCalcium channel blocker useAdverse outcomesChannel blockersBlocker useEligible patientsMyocardial infarctionRelative riskMortality rateAcute myocardial infarction survivorsBaseline risk variablesCardiac hospital readmissionsElderly AMI survivorsBeta-blocker therapyBeta-blocker usePredictors of survivalRisk of deathRetrospective cohort designAcute myocardial infarctionDemonstrable adverse effectsMyocardial infarction survivorsPrescription drug coverageMeasurable adverse outcomesBeta blockersElderly patients